Rapid immune reconstitution following autologous hematopoietic stem cell transplantation in children: A single institution experience

Bone Marrow Transplantation

Volumn 31, Issue 4, 2003, Pages 285-290

  Hoepfner, S ^a   Haut, P R ^a   O'Gorman, M ^a   Kletzel, M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Autologous; Immune reconstitution; Stem cell transplantation

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; ACICLOVIR; ANTIBIOTIC AGENT; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; FLUCONAZOLE; IMMUNOGLOBULIN; MITOGENIC AGENT;

ARTICLE; AUTOGRAFT; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; FEMALE; FEVER; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE SYSTEM; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTE TRANSFORMATION TEST; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PATIENT INFORMATION; PRIORITY JOURNAL; PROVOCATION TEST; QUANTITATIVE ASSAY;

ANTIGENS, CD; ANTIGENS, CD3; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNITY; MALE; NEOPLASMS; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0037298058     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703831     Document Type: Article

References (31)

1. Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987; 69: 369-380.
2. Guillaume T, Rubinstein DB, Symann M. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplant. Blood 1998; 92: 1471-1490.
3. Roberts MM, To LB, Gillis D et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant 1993; 12: 469-475.
4. Parra C, Roldan E, Rodriguez C et al. Reconstitution of peripheral blood lymphocytes in patients treated with bone marrow transplantation: comparison between allogeneic and autologous transplantation. Med Clin (Barc) 1999; 113: 1-5.
5. Kiesel S, Pezzutto A, Körbling M et al. Autologous peripheral stem cell transplantation: analysis of autografted cells and lymphocyte recovery. Transplant Proc 1989; 21: 3084-3088.
6. San Miguel JF, Hernandez MD, Gonzales M et al. A randomized study comparing the effect of GM-CSF and G-CSF on immune reconstitution after autologous bone marrow transplantation. Br J Haemotol 1996; 94: 140-147.
7. Mackall CL, Stein D, Fleisher TA et al. Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults. Blood 2000; 96: 754-762.
8. Kamani N, Kattamis A, Carroll A et al. Immune reconstitution after autologous purged bone marrow transplantation in children. J Pediatr Hematol Oncol 2000; 22: 13-19.
9. Takaue Y, Okamoto Y, Kawano Y et al. Regeneration of immunity and varicella-zoster virus infection after high-dose chemotherapy and peripheral blood stem cell autografts in children. Bone Marrow Transplant 1994; 14: 219-223.
10. Figuerres E, Haut PR, Olzewski M, Kletzel M. Analysis of parameters affecting engraftment in children undergoing autologous peripheral blood stem cell transplants. Bone Marrow Transplant 2000; 25: 583-588.
11. Kletzel M, Haut PR, Olzewski M, Figuerres E. Analysis of parameters engraftment in children undergoing allogeneic BM transplants. Cytotherapy 1999; 1: 417-422.
12. Siena S, Castro-Malaspina H, Gulati SC et al. Effects of in vitro purging with 4-hydroperoxycyclophosphamide on the hematopoietic and microenvironmental elements of human bone marrow. Blood 1985; 65: 655-662.
13. Kemshead JT. Immunomagnetic manipulation of hematopoietic cells: a review of current technology. J Hematotherapy 1992; 1: 35-44.
14. Mackall CL. T-cell immunodeficiency following cytotoxic antineoplastic therapy: a review. Oncologist 1999; 4: 370-378.
15. Gershwin ME, Goetzl EJ, Steinberg AD. Cyclophosphamide: use in practice. Ann Intern Med 1974; 80: 531-540.
16. Samlowski W, Johnson H, Hammond E et al. Marrow ablative doses of gamma-irradiation and protracted changes in peripheral lymph node microvasculature of murine and human bone marrow recipients. Lab Invest 1987; 56: 85-95.
17. Koehne G, Zeller W, Stockschlaeder M, Zander AR. Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1997; 19: 149-156.
18. Olsen GA, Gockermann JP, Bast RC et al. Altered immunologic reconstitution after standard-dose chemotherapy or high-dose chemotherapy with autologous bone marrow support. Transplant 1988; 46: 57-60.
19. Henon PR, Liang H, Beck-Wirth G et al. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant 1992; 9: 285-291.
20. Ashihara E, Shimazaki C, Yamagata N et al. Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two-color flow cytometric analysis. Bone Marrow Transplant 1994; 13: 377-381.
21. Rutella S, Rumi C, Laurenti L et al. Immune reconstitution after transplantation of autologous peripheral CD34+ cells: analysis of predictive factors and comparison with unselected progenitor transplants. Br J Haematol 2000; 108: 105-115.
22. Shenoy S, Mohanakumar T, Todd G et al. Immune reconstitution following allogeneic peripheral blood stem cell transplants. Bone Marrow Transplant 1999; 23: 335-346.
23. Talmadge J, Reed E, Ino K et al. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant 1997; 19: 161-172.
24. Charbonnier A, Sainty D, Faucher C et al. Immune reconstitution after blood cell transplantation. Hematol Cell Ther 1997; 39: 261-264.
25. Armitage RJ, Goldstone AH, Richards JDM, Cawley JC. Lymphocyte function after autologous bone marrow transplantation (BMT): a comparison with patients treated with allogeneic BMT and with chemotherapy only. Br J Hematol 1986; 63: 637-647.
26. Bengtsson M, Totterman TH, Smedmyr B et al. Regeneration of functional and activated NK and T sub-subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 2/3-color FACS analysis. Leukemia 1989; 3: 68-75.
27. Mackall CL, Fleisher TA, Brown MR et al. Distinctions between CD8 + and CD4 + T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 1997; 89: 3700-3707.
28. Scheid C, Pettengell R, Ghielmini M et al. Time-course of the recovery of cellular immune function after high-dose chemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma. Bone Marrow Transplant 1995; 15: 901-906.
29. Ho AD, Maruyama M, Maghazachi A et al. Soluble CD4, soluble CD8 soluble CD25, lymphopoieitic, recovery and endogenous cytokines after high-dose chemotherapy and blood stem cell transplantation. Blood 1994; 84: 3550-3557.
30. Foot AB, Potter MN, Donaldson C et al. Immune reconstitution after BMT in children. Bone Marrow Transplant 1993; 11: 7-13.
31. Leino L, Lilius EM, Nikoskelainen J et al. The reappearance of 10 differentiation antigens on peripheral blood lymphocytes after allogeneic bone marrow transplantation. Bone Marrow Transplant 1991; 8: 339-344.